Our finding that patients with elevated pre-infection ALT and AST levels are also at increased risk of severe COVID-19 may be important for early identification of high-risk individuals, as ALT and AST measurements are components of widely administered comprehensive metabolic panel screening tools. This evidence concerns the gene GPT and COVID-19.